Mitral Valve Lithotripsy With SmartCrack Balloon for Severe Calcified Mitral Stenosis: First‐in‐Human Experience
Journal of the American Heart Association · 2026
DOI: 10.1161/jaha.126.050755 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Kent Chak-Yu So und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine and Therapeutics The Chinese University of Hong Kong Hong Kong SAR China. Hauptthemen laut MEDLINE: Mitral Valve Stenosis, Calcinosis, Rheumatic Heart Disease, Lithotripsy. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Mitral stenosis due to mitral annular calcification and calcific rheumatic heart disease (CRHD) remains challenging to treat. This first‐in‐human study evaluated the safety and feasibility of the dedicated SmartCrack lithotripsy balloon in patients with severe mitral stenosis secondary to mitral annular calcification or calcific rheumatic heart disease.
Methods
High surgical risk patients underwent mitral lithotripsy with the SmartCrack system. Intraoperative measures included mitral valve area, transmitral pressure gradient, and mitral regurgitation severity, assessed pre‐ and post procedure. Follow‐up computed tomography evaluated calcification changes. The primary safety end point was adverse events within 7 days (death, stroke, or procedural complications). The primary efficacy end point was mitral valve area >1.5 cm 2 , ≥50% reduction in transmitral pressure gradient, or transmitral pressure gradient
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Department of Medicine and Therapeutics The Chinese University of Hong Kong Hong Kong SAR China.
- Li Ka Shing Institutes of Health Science, Prince of Wales Hospital The Chinese University of Hong Kong Hong Kong SAR China.
- Department of Imaging and Interventional Radiology Prince of Wales Hospital Hong Kong SAR China.
- Cardiovascular center Taipei Veterans General Hospital Taipei Taiwan.
- Division of Cardiology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University Bangkok Thailand.
- Division of Cardiothoracic Surgery, Department of Surgery Prince of Wales Hospital, The Chinese University of Hong Kong Hong Kong SAR China.
ORCID-Profile: Kent Chak-Yu So, Kevin Ka-Ho Kam, Ling Na Geri Wong, Ching-Wei Lee, Tawai Ngernsritrakul, Leo Kar Lok Lai, Simon Chow, Shing Fung Chui, Michael Lee, Albert K M Chan, Randolph Wong, Thomas Modine, Hasan Jilaihawi, Yat-Yin Lam, Dee Dee Wang, Bryan Yan, Alex Pui-Wai Lee
Zitieren
APA
So, K. C., Kam, K. K., Wong, L. N. G., Hui, W. H. A., Lee, C. W., Ngernsritrakul, T., Lai, L. K. L., Chow, S., Chui, S. F., Lee, M., Chan, A. K. M., Wong, R., Modine, T., Jilaihawi, H., Lam, Y. Y., Wang, D. D., Yan, B., & Lee, A. P. (2026). Mitral Valve Lithotripsy With SmartCrack Balloon for Severe Calcified Mitral Stenosis: First‐in‐Human Experience. Journal of the American Heart Association. https://doi.org/10.1161/jaha.126.050755
Vancouver
So KC, Kam KK, Wong LNG, Hui WHA, Lee CW, Ngernsritrakul T, et al. Mitral Valve Lithotripsy With SmartCrack Balloon for Severe Calcified Mitral Stenosis: First‐in‐Human Experience. Journal of the American Heart Association. 2026. doi:10.1161/jaha.126.050755
BibTeX
@article{So2026,
author = {So, Kent Chak-Yu and Kam, Kevin Ka-Ho and Wong, Ling Na Geri and Hui, Wang Hei Anselm and Lee, Ching-Wei and Ngernsritrakul, Tawai and Lai, Leo Kar Lok and Chow, Simon and Chui, Shing Fung and Lee, Michael and Chan, Albert K M and Wong, Randolph and Modine, Thomas and Jilaihawi, Hasan and Lam, Yat-Yin and Wang, Dee Dee and Yan, Bryan and Lee, Alex Pui-Wai},
title = {Mitral Valve Lithotripsy With SmartCrack Balloon for Severe Calcified Mitral Stenosis: First‐in‐Human Experience},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.126.050755}
}
EUVIMED